November 14, 2022
Business Insider
Related News
-
June 30, 2026Cellares Accepted to FDA’s Inaugural Manufacturing PreCheck Cohort, the Only Cell Therapy Platform Among Seven Companies Nationwide
-
June 15, 2026
Cellares Grows Series D to $327 Million with $50 Million Prime Radiant Partners Investment
-
June 10, 2026
Cellares Joins New American Industrial Alliance, Advancing U.S. Biopharmaceutical Manufacturing Independence
